Atripla and Drug screen false positive - a phase IV clinical study of FDA data

Summary:

Drug screen false positive is reported as a side effect among people who take Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate), especially for people who are male, 50-59 old, also take Ambien,.

The phase IV clinical study analyzes which people have Drug screen false positive when taking Atripla. It is created by eHealthMe based on reports of 35,479 people who have side effects when taking Atripla from the FDA, and is updated regularly.

What is Atripla?

Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 36,036 Atripla users. Check the latest studies of Atripla.

What is Drug screen false positive?

Drug screen false positive is found to be associated with 165 drugs and 482 conditions by eHealthMe. Check the latest studies of Drug screen false positive.

On Aug, 02, 2026

35,479 people reported to have side effects when taking Atripla.
Among them, 22 people (0.06%) have Drug screen false positive.

Could Atripla cause Drug screen false positive?

Among these 22 people:

What is the gender of people who have Drug screen false positive when taking Atripla? *

female: 4.76 %
male: 95.24 %

What is the age of people who have Drug screen false positive when taking Atripla? *

What are other drugs people take besides Atripla? *

What are other side effects people have besides Drug screen false positive? *

Procedural Pain: 1 person, 4.55%
Injury: 1 person, 4.55%
Drug Screen Positive: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Atripla and have Drug screen false positive?

- Check whether Drug screen false positive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atripla:

Atripla (36,036 reports)

Drug screen false positive treatments and more:

Drug screen false positive (2,999 reports)

How severe was Drug screen false positive and when was it recovered:

Drug screen false positive in Atripla

Expand to all the drugs that have ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate:

Drug screen false positive and drugs with ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atripla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug screen false positive:

Drug screen false positive (165 drugs)

Browse all the conditions that are associated with Drug screen false positive:

Drug screen false positive (482 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on efavirenz; emtricitabine; tenofovir disoproxil fumarate (the active ingredients of Atripla) and Atripla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.